During the past decade, Helsingborg Hospital conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 7 clinical trials were completed, i.e. on average, 18.4% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 4 clinical trials were completed. i.e. 23.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Helsingborg Hospital" #1 sponsor was "Region Skane" with 12 trials, followed by "Karolinska Institutet" with 6 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Helsingborgs Hospital" with 4 trials sponsored and "Uppsala University" with 4 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Helsingborg Hospital" #1 collaborator was "Lund University" with 7 trials as a collaborator, "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 5 trials as a collaborator, "The Swedish Research Council" with 4 trials as a collaborator, "Uppsala University" with 3 trials as a collaborator and "DexCom, Inc." with 2 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 50 trials.

According to Clinical.Site data, the most researched conditions in "Helsingborg Hospital" are "Multiple Myeloma" (8 trials), "Breast Cancer" (4 trials), "Out-of-hospital Cardiac Arrest" (3 trials), "Prostate Cancer" (3 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Helsingborg Hospital" in a lesser frequency.

Most popular intervention types in "Helsingborg Hospital" are "Drug" (28 trials), "Other" (11 trials), "Device" (9 trials), "Procedure" (9 trials) and "Diagnostic Test" (6 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (5 trials), "Bortezomib" (4 trials), "Pomalidomide" (4 trials), "Daratumumab" (3 trials) and "Placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Helsingborg Hospital" are 52 trials for "All" genders, 7 trials for "Male" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Helsingborg Hospital". 1 are not yet recruiting, 19 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Helsingborg Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Helsingborg Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 29 trials that are defined as “Not Applicable".